ArticleOpen veterinary journal2025
Ameliorative potential of quercetin on the possible adverse effects of ketoprofen.
Article in Open veterinary journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ketoprofen (KP) is a non-steroidal anti-inflammatory drug that treats musculoskeletal injuries, osteoarthritis, and acute gouty arthritis. However, its use has been linked to certain detrimental effects on the stomach, liver, and renal function. Aim: This study investigated the ameliorative effects of omeprazole and quercetin on the negative effects of KP in rats. Methods: The experimental rats were randomly divided into four groups: Group I consisted of negative control rats. Rats were treated with KP in Group II (50 mg/kg b.wt.), omeprazole in Group III (20 mg/kg b.wt.), and quercetin in Group IV 1 h before KP (50 mg/kg b.wt.). Gastric juice volume and pH, gastric ulcer, ulcer score, and curative ratio, serum biochemical analysis (liver function and kidney function), and evaluation of gastric, hepatic, and renal oxidant/antioxidant status were all evaluated. Results: The obtained results showed significant ameliorative effects of omeprazole and quercetin against the induced alterations in the liver and kidney function tests compared with those in nontreated rats. In addition, KP caused significant oxidative damage, which was significantly improved upon omeprazole and quercetin administration. Conclusion: Therefore, it is highly recommended that either omeprazole or quercetin be used during the treatment course by KP to decrease its induced adverse effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.